Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Genomic Selection Platform Market Growth Potential: How Will Market Size Shift Through 2030?
The genomic selection platform market size has experienced significant growth in recent years. It is projected to expand from $2.27 billion in 2025 to $2.66 billion in 2026, at a compound annual growth rate (CAGR) of 17.1%. The historical increase can be ascribed to the expansion of molecular breeding programs, enhanced availability of genotyping technologies, the adoption of statistical genomics models, a surging demand for quicker breeding cycles, and increasing research investments in genetics.
The genomic selection platform market is projected to experience swift expansion over the coming years. By 2030, this market is anticipated to reach a valuation of $4.96 billion, demonstrating a compound annual growth rate (CAGR) of 16.8%. This projected increase can be linked to several factors, including the greater integration of genomic selection within agriculture, the growing application of predictive analytics in breeding programs, the broadening scope of sustainable crop and livestock development, the increasing combination of genomics with precision agriculture, and improvements in cloud-native genomic platforms. Key developments expected during this timeframe encompass the wider embrace of AI-powered genomic prediction models, the increasing utilization of high-throughput genotyping platforms, the deeper incorporation of cloud-based breeding analytics, the proliferation of predictive breeding decision support systems, and a heightened emphasis on the accuracy of trait-based selection.
Get A Free Sample Report With In-Depth Market Insights:
Genomic Selection Platform Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The rising embrace of personalized medicine is projected to stimulate expansion in the Genomic Selection Platform Market moving forward. This medical strategy involves customizing treatment and preventative measures based on an individual’s distinct genetic profile, lifestyle, and environmental factors. Its growing popularity stems mainly from breakthroughs in genomics, which allow for the accurate detection of genetic variations and the creation of bespoke therapies for patients. Genomic Selection Platforms facilitate personalized medicine by offering exact genomic data, thereby proving highly suitable for customizing patient treatments. These platforms minimize guesswork in choosing therapies through predicting responses to interventions, thereby enhancing treatment efficacy and patient results. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, marking a substantial rise from the 12 approved in 2022. Consequently, the expanding use of personalized medicine is propelling the advancement of the Genomic Selection Platform Market.
Genomic Selection Platform Market Segmentation And Category Overview
The genomic selection platform market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications
4) By End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End-Users
Subsegments:
1) By Software: Genomic Data Management Software, Bioinformatics And Statistical Analysis Tools, DNA Or RNA Sequencing Data Processing Software, Genomic Prediction And Modeling Software, Cloud-Based Genomic Platforms, Workflow Automation And Integration Tools
2) By Hardware: Next-Generation Sequencing (NGS) Systems, Polymerase Chain Reaction (PCR) Instruments, Microarray Analyzers, High-Performance Computing (HPC) Systems, Data Storage Servers, Laboratory Automation And Robotics
3) By Services: Sequencing And Genotyping Services, Data Analysis And Interpretation Services, Cloud Hosting And Data Storage Services, Custom Bioinformatics Solutions, Training And Technical Support Services, Consulting And Implementation Services
Genomic Selection Platform Market Innovation Trends: What Developments Are Reshaping The Industry?
Key companies active in the genomic selection platform market are concentrating on creating novel solutions, such as targeted sequencing platforms, to enhance trait prediction and accelerate breeding initiatives. Targeted sequencing platforms are defined as genomic technologies and systems designed to sequence specific regions of the genome rather than the entire genome. For instance, in October 2024, Element Biosciences Inc., a US-based life sciences technology company, launched Trinity, an innovative targeted sequencing platform that streamlines exome capture by integrating traditionally complex steps directly into its AVITI System. This platform removes the requirement for specialized equipment, reduces manual work by up to five hours, and offers a one-hour hybridization option for same-day results, making it ideal for time-sensitive studies. Trinity’s capabilities extend to supporting custom panels across diverse applications, including oncology, respiratory diseases, and minimal residual disease (MRD). It delivers faster, more cost-effective, and more accessible sequencing, marking the first major advancement in exome capture.
Genomic Selection Platform Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., Enigma Genomics Inc.
View The Full Genomic Selection Platform Market Report:
Genomic Selection Platform Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the genomic selection platform market in 2025. The regions covered in the genomic selection platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model







